Form 4: Molina Healthcare Director Lockhart Awarded Shares

Molina Healthcare Director Stephen H. Lockhart received a grant of 317 shares of common stock as part of his director compensation.

Summary

• Stephen H. Lockhart, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
• The transaction occurred on January 1, 2026, and was a grant under the Issuer's 2025 Equity Incentive Plan for his services as a Director.
• The shares were valued at $173.54 each, based on the closing price of Molina Healthcare's common stock on December 31, 2025, as January 1, 2026, was a non-trading day.
• The aggregate dollar value of the annual equity award to each director is set at $220,000, with one quarter, or $55,000, granted on the first day of each quarter.
• Following this transaction, Stephen H. Lockhart beneficially owns 3,742 shares of Molina Healthcare common stock directly.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected compensation event for a director, which is a neutral to slightly positive signal as it indicates ongoing governance and compensation practices. It does not contain information that would significantly alter the company's outlook or financial position.

Positives

• Stephen H. Lockhart received additional equity compensation for his services as a Director, aligning his interests with shareholders.
• The grant is part of a pre-established 2025 Equity Incentive Plan, indicating structured and transparent director compensation.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the details of the stock grant under the 2025 Equity Incentive Plan.

Industry Context

This routine director compensation grant reflects standard corporate governance practices within the healthcare industry, where equity awards are common for aligning director and shareholder interests. It does not provide specific insights into broader industry trends or competitive positioning.

Comparison to Industry Standards

• The practice of granting equity as part of director compensation is a standard corporate governance practice across various industries, including healthcare, to align the interests of directors with those of shareholders.
• The specific value of the annual equity award ($220,000) and quarterly grants ($55,000) for Molina Healthcare's directors is within the typical range for directors of publicly traded companies of similar market capitalization and industry, though specific comparisons would require detailed compensation surveys of peer companies like Centene Corporation (CNC), Anthem, Inc. (now Elevance Health, ELV), or UnitedHealth Group (UNH).

Corporate Governance

Stakeholder Impact

• Shareholders: The grant represents a routine compensation expense, which is part of the overall cost of governance. It also aligns the director's interests with shareholder value through equity ownership.
• Directors: Stephen H. Lockhart receives compensation for his services, which is a positive for the individual director.

Key Dates

Keywords

Molina Healthcare, MOH, Stephen H. Lockhart, Director Compensation, Stock Grant, Equity Incentive Plan, Insider Transaction, Form 4